You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunomodulating Agents

Showing 1 - 25 of 5,366
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reporting of Antibody-Drug Conjugate Associated Sepsis-related

Completed
  • Sepsis (SMQ)
  • +2 more
  • Antibody-Drug Conjugate
  • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
  • Changsha, Hunan, China
    Central South University
Jun 19, 2022

Reporting of AdVerse Events Associated With AnTicAncerRapy

Recruiting
  • Cancer
  • Antineoplastic and Immunomodulating Agents
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 4, 2021

Reporting of Cardio-vascular Adverse Events With Antineoplastic

Unknown status
  • Cardiac Disease
  • Cancer
  • Antineoplastic and Immunomodulating Agents
  • Paris, France
    AP-HP, Pitié-Salpêtrière Hospital,Department of Pharmacology, CI
Sep 2, 2019

Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

Completed
Has Results
  • Idiopathic Pulmonary Fibrosis
  • L - Antineoplastic and immunomodulating agents
  • +4 more
  • Barcelona, Spain
    Dynamic solutions
Jun 6, 2019

Organoid Model Predictive of Response to Immunotherapies

Recruiting
  • Breast Cancer
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 10, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Immunotherapy in Upper Tract Urothelial Carcinoma

Not yet recruiting
  • Urothelial Carcinoma
  • Evaluation of anti-PD-(L)1 immunotherapy efficacy
  • (no location specified)
Oct 27, 2023

Omitting Clinical Target Volume in Radical Treatment of

Not yet recruiting
  • Immunotherapy
  • +3 more
  • IMRT+adjuvant immunotherapy
  • (no location specified)
Jun 9, 2023

e-ITAG Allergen Immunotherapy in Management of Allergic Asthma

Recruiting
  • Study the Efficacy of ITA in Patients With Allergic Asthma or Allergic Rhinitis or Allergic Rhinitis Compared With Conventional Treatment
  • Tunis, Montfleury, Tunisia
    Military Hospital of Tunis
Aug 26, 2023

COVID-19 Trial in Taipei (P1101 (Ropeginterferon alfa-2b), SOC)

Active, not recruiting
  • COVID-19
  • P1101 (Ropeginterferon alfa-2b)
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 13, 2023

NSCLC Trial in Shanghai (Toripalimab, Cryoablation)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 7, 2023

Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Stereotactic body radiation(SBRT)
  • Zimberelimab (GLS-010)
  • (no location specified)
Aug 22, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Genomic Data of American Indian Patient Population

Active, not recruiting
  • Immune Checkpoint Inhibitors
  • +6 more
  • Immunotherapy
  • Tucson, Arizona
  • +5 more
May 8, 2023

Immunomodulators Associated With Atrial Fibrillation Reporting:

Completed
  • Atrial Fibrillation
  • Immunomodulators with FDA approval on the 1st January 2023.
  • Caen, Basse Normandie, France
    Alexandre Joachim
Oct 17, 2023

Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

Not yet recruiting
  • Elderly Patients
  • Metastatic Lung Cancer
  • Single drug chemotherapy plus immunotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 15, 2023

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Split-course hypo-CCRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Aug 26, 2023

NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • radiotherapy
  • +3 more
  • (no location specified)
Sep 10, 2023

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

Recruiting
  • Non-Small Cell Lung Cancer
  • Neoadjuvant immunochemotherapy
  • Neoadjuvant chemotherapy
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Aug 1, 2023

Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy

Recruiting
  • Urothelial Carcinoma
  • Radiotherapy
  • +2 more
  • Beijing, China
  • +2 more
Nov 2, 2023

NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Rotterdam, Netherlands
    Erasmus MC
Jun 5, 2023

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Advanced Ovarian Cancer Trial in Guangzhou (Plasmodium immunotherapy)

Not yet recruiting
  • Advanced Ovarian Cancer
  • Plasmodium immunotherapy
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Southern Medical University
Jul 5, 2023

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

S100A8/A9 and Innate Immunity in Liver Disease

Recruiting
  • Cirrhosis, Liver
  • +4 more
    • London Borough Of Wandsworth, London, United Kingdom
      Arjuna Singanayagam
    Mar 30, 2023